Trial Profile
Reverse Transcriptase Inhibitors in Aicardi Goutieres Syndrome
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 Jan 2024
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications Congenital abnormalities; Hepatitis B; HIV infections; Primary biliary cirrhosis
- Focus Pharmacodynamics
- Acronyms RTIAGS
- 03 Jan 2024 Planned initiation date changed from 1 Dec 2023 to 1 Dec 2024.
- 17 Jan 2023 Planned End Date changed from 1 Dec 2027 to 1 Dec 2028.
- 17 Jan 2023 Planned primary completion date changed from 1 Dec 2027 to 1 Dec 2028.